Predicting risk of disability

June 24, 2015

Two articles published recently by Australian and international investigators using the MSBase database provide insight into several factors that most strongly predict the risk of accumulating MS-related more

NZ Incidence Study

June 21, 2015

Incidence studies are a well validated tool to better elucidate the cause and risk factors of a disease and plan effective preventive and management strategies. New Zealand (NZ) is ideally…read more

Case of PML

June 12, 2015

The pharmaceutical sponsor of Gilenya (fingolimod), Novartis, has this week reported one case of Progressive Multifocal Leukoencephalopathy (PML) in an individual currently being treated with Gilenya in Europeread more

Back to top